Titan Pharmaceuticals (TTNP) Revenue & Revenue Breakdown
Titan Pharmaceuticals Revenue Highlights
Latest Revenue (Y)
$184.00K
Main Segment (Y)
Grant revenue
Main Geography (Y)
Grant revenue
Titan Pharmaceuticals Revenue by Period
Titan Pharmaceuticals Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $184.00K | 206.67% |
2022-12-31 | $60.00K | -96.07% |
2021-12-31 | $1.53M | -68.46% |
2020-12-31 | $4.84M | 33.98% |
2019-12-31 | $3.61M | -38.91% |
2018-12-31 | $5.91M | 2649.30% |
2017-12-31 | $215.00K | -98.57% |
2016-12-31 | $15.06M | 801.56% |
2015-12-31 | $1.67M | -54.17% |
2014-12-31 | $3.65M | -65.21% |
2013-12-31 | $10.48M | 47.27% |
2012-12-31 | $7.12M | 74.95% |
2011-12-31 | $4.07M | -59.69% |
2010-12-31 | $10.09M | 12675.95% |
2009-12-31 | $79.00K | 12.86% |
2008-12-31 | $70.00K | 191.67% |
2007-12-31 | $24.00K | -25.00% |
2006-12-31 | $32.00K | -64.04% |
2005-12-31 | $89.00K | 187.10% |
2004-12-31 | $31.00K | -65.17% |
2003-12-31 | $89.00K | -96.92% |
2002-12-31 | $2.89M | -36.75% |
2001-12-31 | $4.57M | 143.19% |
2000-12-31 | $1.88M | 526.67% |
1999-12-31 | $300.00K | 200.00% |
1998-12-31 | $100.00K | -99.43% |
1997-12-31 | $17.50M | 5733.33% |
1996-12-31 | $300.00K | 200.00% |
1995-12-31 | $100.00K | - |
Titan Pharmaceuticals Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $81.00K | 1925.00% |
2023-09-30 | $4.00K | 300.00% |
2023-06-30 | $1.00K | -98.98% |
2023-03-31 | $98.00K | 92.16% |
2022-12-31 | $51.00K | 1175.00% |
2022-09-30 | $4.00K | -97.33% |
2022-06-30 | $150.00K | -21.88% |
2022-03-31 | $192.00K | 42.22% |
2021-12-31 | $135.00K | -48.86% |
2021-09-30 | $264.00K | -40.67% |
2021-06-30 | $445.00K | -34.75% |
2021-03-31 | $682.00K | -35.48% |
2020-12-31 | $1.06M | -5.63% |
2020-09-30 | $1.12M | -15.47% |
2020-06-30 | $1.32M | -0.82% |
2020-03-31 | $1.34M | 9.78% |
2019-12-31 | $1.22M | 28.51% |
2019-09-30 | $947.00K | 88.65% |
2019-06-30 | $502.00K | -46.88% |
2019-03-31 | $945.00K | 78.30% |
2018-12-31 | $530.00K | -67.88% |
2018-09-30 | $1.65M | -38.16% |
2018-06-30 | $2.67M | 150.75% |
2018-03-31 | $1.06M | 1734.48% |
2017-12-31 | $58.00K | 45.00% |
2017-09-30 | $40.00K | -48.05% |
2017-06-30 | $77.00K | 92.50% |
2017-03-31 | $40.00K | 14.29% |
2016-12-31 | $35.00K | 34.62% |
2016-09-30 | $26.00K | -99.83% |
2016-06-30 | $15.00M | 100.00% |
2016-03-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2015-09-30 | - | -100.00% |
2015-06-30 | $760.00K | -16.58% |
2015-03-31 | $911.00K | -0.11% |
2014-12-31 | $912.00K | 0.11% |
2014-09-30 | $911.00K | - |
2014-06-30 | $911.00K | - |
2014-03-31 | $911.00K | - |
2013-12-31 | $911.00K | -58.55% |
2013-09-30 | $2.20M | - |
2013-06-30 | $2.20M | -57.52% |
2013-03-31 | $5.17M | 58.76% |
2012-12-31 | $3.26M | 165.39% |
2012-09-30 | $1.23M | -9.71% |
2012-06-30 | $1.36M | 7.09% |
2012-03-31 | $1.27M | -10.12% |
2011-12-31 | $1.41M | 39.62% |
2011-09-30 | $1.01M | 45.61% |
2011-06-30 | $695.00K | -26.69% |
2011-03-31 | $948.00K | -65.22% |
2010-12-31 | $2.73M | -24.28% |
2010-09-30 | $3.60M | 168.26% |
2010-06-30 | $1.34M | -44.66% |
2010-03-31 | $2.42M | 8881.48% |
2009-12-31 | $27.00K | 100.00% |
2009-09-30 | - | -100.00% |
2009-06-30 | $29.00K | 26.09% |
2009-03-31 | $23.00K | 100.00% |
2008-12-31 | - | 100.00% |
2008-09-30 | - | -100.00% |
2008-06-30 | $12.00K | -80.33% |
2008-03-31 | $61.00K | 408.33% |
2007-12-31 | $12.00K | - |
Titan Pharmaceuticals Revenue Breakdown
Titan Pharmaceuticals Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|
Grant revenue | $1.28M | - | - |
License revenue | $13.00K | - | - |
Product revenue | $236.00K | - | - |
License And Service | - | $11.00K | $315.00K |
Manufactured Product Other | - | $528.00K | $1.01M |
Grant | - | $4.30M | $2.29M |
Latest
Quarterly Revenue by Product
Product/Service | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Product revenue | - | - | - | $36.00K | - | - | - | - | - | - | - | - | - |
Grant revenue | $147.00K | $189.00K | $131.00K | $224.00K | - | - | - | - | - | - | - | - | - |
License revenue | $3.00K | $3.00K | $4.00K | $4.00K | - | - | - | - | - | - | - | - | - |
Manufactured Product Other | - | - | - | - | $89.00K | $111.00K | $101.00K | $102.00K | $115.00K | $210.00K | $195.00K | $190.00K | $304.00K |
License And Service | - | - | - | - | $3.00K | $2.00K | $5.00K | - | $6.00K | - | $2.00K | - | - |
Grant | - | - | - | - | $353.00K | $569.00K | $951.00K | $1.02M | $1.20M | $1.13M | $1.02M | $757.00K | $198.00K |
Latest
Titan Pharmaceuticals Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 21 | Dec 20 | Dec 19 |
---|---|---|---|
License revenue | $13.00K | - | - |
Product revenue | $236.00K | - | - |
Grant revenue | $1.28M | - | - |
Manufactured Product Other | - | $528.00K | $1.01M |
Grant | - | $4.30M | $2.29M |
License And Service | - | $11.00K | $315.00K |
Latest
Quarterly Revenue by Country
Country | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Grant revenue | $147.00K | $189.00K | $131.00K | $224.00K | - | - | - | - | - | - | - | - | - |
License revenue | $3.00K | $3.00K | $4.00K | $4.00K | - | - | - | - | - | - | - | - | - |
Product revenue | - | - | - | $36.00K | - | - | - | - | - | - | - | - | - |
Manufactured Product Other | - | - | - | - | $89.00K | $111.00K | $101.00K | $102.00K | $115.00K | $210.00K | $195.00K | $190.00K | $304.00K |
Grant | - | - | - | - | $353.00K | $569.00K | $951.00K | $1.02M | $1.20M | $1.13M | $1.02M | $757.00K | $198.00K |
License And Service | - | - | - | - | $3.00K | $2.00K | $5.00K | - | $6.00K | - | $2.00K | - | - |
Latest
Titan Pharmaceuticals Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
FHTX | Foghorn Therapeutics | $34.16M | $7.81M |
SNTI | Senti Biosciences | $2.56M | - |
SABS | SAB Biotherapeutics | $2.24M | $263.14K |
VCNX | Vaccinex | $570.00K | $52.00K |
TTNP | Titan Pharmaceuticals | $184.00K | - |
NRBO | NeuroBo Pharmaceuticals | $7.00K | - |
LIXT | Lixte Biotechnology | - | - |
PCSA | Processa Pharmaceuticals | - | - |
CVKD | Cadrenal Therapeutics | - | - |
GOVX | GeoVax Labs | - | $300.68K |
THRD | Third Harmonic Bio | - | - |
INDP | Indaptus Therapeutics | - | - |
QNRX | Quoin Pharmaceuticals | - | - |
SLRX | Salarius Pharmaceuticals | - | - |
KTTA | Pasithea Therapeutics | - | - |